Lactate's impact on immune cells in sepsis: unraveling the complex interplay.

Tao Zhang, Linjian Chen, Gatkek Kueth, Emily Shao, Xiaohui Wang, Tuanzhu Ha, David L Williams, Chuanfu Li, Min Fan, Kun Yang
Author Information
  1. Tao Zhang: Department of Biomedical Sciences, James H Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.
  2. Linjian Chen: Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.
  3. Gatkek Kueth: James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.
  4. Emily Shao: Program in Neuroscience, College of Arts and Science, Vanderbilt University, Nashville, TN, United States.
  5. Xiaohui Wang: Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.
  6. Tuanzhu Ha: Department of Biomedical Sciences, James H Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.
  7. David L Williams: Department of Biomedical Sciences, James H Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.
  8. Chuanfu Li: Department of Biomedical Sciences, James H Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.
  9. Min Fan: Department of Biomedical Sciences, James H Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.
  10. Kun Yang: Department of Biomedical Sciences, James H Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.

Abstract

Lactate significantly impacts immune cell function in sepsis and septic shock, transcending its traditional view as just a metabolic byproduct. This review summarizes the role of lactate as a biomarker and its influence on immune cell dynamics, emphasizing its critical role in modulating immune responses during sepsis. Mechanistically, key lactate transporters like MCT1, MCT4, and the receptor GPR81 are crucial in mediating these effects. HIF-1α also plays a significant role in lactate-driven immune modulation. Additionally, lactate affects immune cell function through post-translational modifications such as lactylation, acetylation, and phosphorylation, which alter enzyme activities and protein functions. These interactions between lactate and immune cells are central to understanding sepsis-associated immune dysregulation, offering insights that can guide future research and improve therapeutic strategies to enhance patient outcomes.

Keywords

References

  1. Biomolecules. 2021 Jul 10;11(7): [PMID: 34356636]
  2. Nat Metab. 2023 Mar;5(3):431-444 [PMID: 36797420]
  3. Crit Care Med. 2017 May;45(5):875-882 [PMID: 28296810]
  4. Genome Biol. 2021 Mar 16;22(1):85 [PMID: 33726814]
  5. J Neuroinflammation. 2018 Nov 13;15(1):313 [PMID: 30424795]
  6. BMC Cancer. 2022 Jan 6;22(1):39 [PMID: 34991504]
  7. J Physiol. 2008 Mar 15;586(6):1767-75 [PMID: 18218678]
  8. J Clin Invest. 2013 Sep;123(9):3685-92 [PMID: 23999443]
  9. Front Physiol. 2021 Oct 18;12:688485 [PMID: 34733170]
  10. Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18327-32 [PMID: 19815506]
  11. Nat Rev Cancer. 2003 Oct;3(10):721-32 [PMID: 13130303]
  12. Blood. 2007 May 1;109(9):3812-9 [PMID: 17255361]
  13. Nat Commun. 2020 Jul 15;11(1):3547 [PMID: 32669546]
  14. Cancers (Basel). 2023 Jan 12;15(2): [PMID: 36672426]
  15. Blood. 2004 Aug 15;104(4):1100-9 [PMID: 15113757]
  16. N Engl J Med. 2001 Nov 8;345(19):1368-77 [PMID: 11794169]
  17. Cells. 2021 Jun 30;10(7): [PMID: 34208876]
  18. Blood. 2010 Jun 10;115(23):4742-9 [PMID: 20351312]
  19. Am J Respir Crit Care Med. 2019 Sep 1;200(5):582-589 [PMID: 30985210]
  20. Immunity. 2010 Nov 24;33(5):657-70 [PMID: 21094463]
  21. Int J Biol Sci. 2022 Oct 24;18(16):6210-6225 [PMID: 36439872]
  22. Am Fam Physician. 2022 Nov;106(5):589-590 [PMID: 36379484]
  23. Intensive Care Med. 2007 Jun;33(6):970-7 [PMID: 17431582]
  24. Intensive Care Med. 2007 Nov;33(11):1967-71 [PMID: 17661014]
  25. Sci Adv. 2021 Jun 23;7(26): [PMID: 34162546]
  26. Am J Cancer Res. 2021 Nov 15;11(11):5726-5742 [PMID: 34873490]
  27. Elife. 2020 Oct 23;9: [PMID: 33095157]
  28. J Infect Dis. 2005 Apr 15;191(8):1280-6 [PMID: 15776374]
  29. PLoS One. 2020 Sep 11;15(9):e0238524 [PMID: 32915806]
  30. Sci Adv. 2023 Feb 3;9(5):eadc9465 [PMID: 36735787]
  31. J Physiol. 2021 Feb;599(3):863-888 [PMID: 32358865]
  32. Nat Rev Immunol. 2013 Dec;13(12):862-74 [PMID: 24232462]
  33. Mol Cell. 2023 Nov 2;83(21):3904-3920.e7 [PMID: 37879334]
  34. Clin Biochem. 2017 Nov;50(16-17):956-958 [PMID: 28552399]
  35. Crit Care Med. 1983 Jun;11(6):449-51 [PMID: 6406145]
  36. JAMA. 2010 Feb 24;303(8):739-46 [PMID: 20179283]
  37. Immunol Rev. 2017 May;277(1):61-75 [PMID: 28462526]
  38. Chest. 1991 Apr;99(4):956-62 [PMID: 2009802]
  39. Gut. 2021 Dec;70(12):2238-2248 [PMID: 33487592]
  40. Nature. 2021 Mar;591(7851):645-651 [PMID: 33589820]
  41. Front Neurosci. 2015 Feb 27;9:22 [PMID: 25774123]
  42. IUBMB Life. 2019 Dec;71(12):2010-2019 [PMID: 31444899]
  43. Nat Immunol. 2013 Oct;14(10):986-95 [PMID: 24048120]
  44. Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):14116-21 [PMID: 22893686]
  45. Cell Mol Life Sci. 2014 Jul;71(14):2577-604 [PMID: 24363178]
  46. J Mol Cell Cardiol. 1992 Jul;24(7):669-81 [PMID: 1404407]
  47. Oncoimmunology. 2022 Dec 22;12(1):2160558 [PMID: 36567801]
  48. Nat Rev Cancer. 2012 Mar 22;12(4):265-77 [PMID: 22437871]
  49. Cancer Res. 2014 Sep 15;74(18):5301-10 [PMID: 24928781]
  50. Cell. 2013 Aug 1;154(3):651-63 [PMID: 23911327]
  51. Oncogene. 2019 May;38(19):3681-3695 [PMID: 30664688]
  52. JAMA. 2016 Feb 23;315(8):801-10 [PMID: 26903338]
  53. Nat Metab. 2020 Jul;2(7):566-571 [PMID: 32694798]
  54. Immunity. 2024 Mar 12;57(3):528-540.e6 [PMID: 38417442]
  55. J Microbiol Immunol Infect. 2021 Jun;54(3):404-410 [PMID: 31727535]
  56. Intensive Care Med. 1996 Jan;22(1):6-16 [PMID: 8857432]
  57. Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):6047-6055 [PMID: 32123114]
  58. Intensive Care Med. 2009 Apr;35(4):678-86 [PMID: 18946659]
  59. Crit Care Med. 2003 Jul;31(7):2068-71 [PMID: 12847405]
  60. Front Nutr. 2023 Feb 16;10:1113739 [PMID: 36875841]
  61. Gastroenterology. 2014 Jun;146(7):1763-74 [PMID: 24657625]
  62. Am J Respir Crit Care Med. 2019 Oct 15;200(8):1069-1070 [PMID: 31206309]
  63. Science. 1999 Jul 9;285(5425):248-51 [PMID: 10398600]
  64. Blood. 2006 Mar 1;107(5):2013-21 [PMID: 16278308]
  65. Stud Hist Philos Biol Biomed Sci. 2010 Sep;41(3):253-62 [PMID: 20934646]
  66. Nat Commun. 2023 Jun 15;14(1):3546 [PMID: 37322053]
  67. Crit Care. 2011;15(1):R70 [PMID: 21349174]
  68. Science. 2012 Feb 3;335(6068):597-601 [PMID: 22245738]
  69. Front Immunol. 2023 Dec 13;14:1323797 [PMID: 38193090]
  70. Mol Nutr Food Res. 2022 Dec;66(24):e2200196 [PMID: 36239154]
  71. Circulation. 1970 Jun;41(6):989-1001 [PMID: 5482913]
  72. FASEB J. 2004 Aug;18(11):1303-5 [PMID: 15180958]
  73. Front Immunol. 2023 Feb 27;14:1101433 [PMID: 36923405]
  74. Nat Immunol. 2011 Mar;12(3):222-30 [PMID: 21151103]
  75. F1000Prime Rep. 2014 Mar 03;6:13 [PMID: 24669294]
  76. Trends Immunol. 2022 Dec;43(12):969-977 [PMID: 36319537]
  77. Cell Rep. 2020 Jul 7;32(1):107855 [PMID: 32640221]
  78. Int J Mol Sci. 2021 Sep 23;22(19): [PMID: 34638575]
  79. Lancet. 2002 Jul 20;360(9328):219-23 [PMID: 12133657]
  80. Sci Adv. 2023 Oct 20;9(42):eadh4655 [PMID: 37851814]
  81. Crit Care. 2011;15(5):R243 [PMID: 22018048]
  82. Nat Immunol. 2018 Dec;19(12):1319-1329 [PMID: 30397348]
  83. Clin Nutr. 2021 May;40(5):2988-2998 [PMID: 33674148]
  84. J Gen Physiol. 1992 Aug;100(2):341-67 [PMID: 1402785]
  85. Cell Death Differ. 2004 Feb;11(2):143-53 [PMID: 14576767]
  86. Nature. 2014 Sep 25;513(7519):559-63 [PMID: 25043024]
  87. Blood Adv. 2024 May 28;8(10):2373-2383 [PMID: 38467031]
  88. Front Immunol. 2023 Apr 26;14:1136964 [PMID: 37180159]
  89. N Engl J Med. 2017 Jun 8;376(23):2223-2234 [PMID: 28320242]
  90. J Immunol. 2009 Feb 15;182(4):2476-84 [PMID: 19201903]
  91. Shock. 2022 Jun 1;57(6):308-317 [PMID: 35759309]
  92. Cell Metab. 2019 Dec 3;30(6):1075-1090.e8 [PMID: 31801055]
  93. Nat Commun. 2023 Nov 4;14(1):7081 [PMID: 37925420]
  94. Antibodies (Basel). 2021 Jun 28;10(3): [PMID: 34203136]
  95. Front Mol Biosci. 2019 Sep 06;6:85 [PMID: 31555665]
  96. Ann Palliat Med. 2022 Feb;11(2):588-597 [PMID: 35249337]
  97. Cancer Immunol Res. 2019 Feb;7(2):335-346 [PMID: 30563827]
  98. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11081-5 [PMID: 1662382]
  99. J Immunol. 2010 Feb 1;184(3):1200-9 [PMID: 20026743]
  100. Int J Mol Sci. 2022 May 26;23(11): [PMID: 35682650]
  101. Nat Commun. 2022 Sep 6;13(1):4981 [PMID: 36068198]
  102. J Exp Med. 2011 Aug 1;208(8):1673-82 [PMID: 21746813]
  103. Can Med Assoc J. 1964 Mar 14;90:673-5 [PMID: 14127378]
  104. J Pharmacol Exp Ther. 2012 Jun;341(3):794-801 [PMID: 22434674]
  105. Crit Care. 2010;14(1):R25 [PMID: 20181242]
  106. Pflugers Arch. 2004 Feb;447(5):619-28 [PMID: 12739169]
  107. Nat Commun. 2014 Jul 14;5:4436 [PMID: 25019241]
  108. Cell Metab. 2017 Jun 6;25(6):1282-1293.e7 [PMID: 28416194]
  109. PLoS One. 2024 Jan 29;19(1):e0291128 [PMID: 38285688]
  110. NMR Biomed. 2013 Jan;26(1):106-14 [PMID: 22711601]
  111. Cell Host Microbe. 2018 Jul 11;24(1):97-108.e4 [PMID: 29937272]
  112. Immunity. 2020 Dec 15;53(6):1136-1150 [PMID: 33326765]
  113. Cell Metab. 2022 May 3;34(5):731-746.e9 [PMID: 35452600]
  114. Eur J Immunol. 1997 May;27(5):1229-35 [PMID: 9174615]
  115. J Immunol. 2019 Jul 15;203(2):453-464 [PMID: 31160535]
  116. J Cell Biol. 1963 Jun;17:487-501 [PMID: 13940299]
  117. Cell Rep. 2024 Mar 26;43(3):113967 [PMID: 38492219]
  118. Nat Rev Immunol. 2017 Jul;17(7):407-420 [PMID: 28436424]
  119. Immunity. 2018 Oct 16;49(4):740-753.e7 [PMID: 30314759]
  120. Mol Aspects Med. 2013 Apr-Jun;34(2-3):337-49 [PMID: 23506875]
  121. Metabolism. 1999 Jun;48(6):779-85 [PMID: 10381154]
  122. Cell Metab. 2016 Nov 8;24(5):657-671 [PMID: 27641098]
  123. Nat Commun. 2023 Oct 27;14(1):6858 [PMID: 37891230]
  124. J Clin Lab Anal. 2019 Sep;33(7):e22942 [PMID: 31265174]
  125. Crit Care Med. 2006 Feb;34(2):344-53 [PMID: 16424713]
  126. J Immunol Res. 2023 Mar 8;2023:6891636 [PMID: 36937004]
  127. Eur J Med Res. 2023 Dec 5;28(1):565 [PMID: 38053180]
  128. Am J Physiol. 1986 Jun;250(6 Pt 1):E634-40 [PMID: 3521310]
  129. APMIS. 2019 Feb;127(2):72-79 [PMID: 30614067]
  130. Proc Natl Acad Sci U S A. 2021 Jun 22;118(25): [PMID: 34161263]
  131. J Trauma Acute Care Surg. 2012 Jun;72(6):1491-501 [PMID: 22695412]
  132. Nat Immunol. 2016 Dec;17(12):1459-1466 [PMID: 27695003]
  133. Science. 2015 Mar 13;347(6227):1260-5 [PMID: 25766237]
  134. Crit Rev Clin Lab Sci. 2013 Jan-Feb;50(1):23-36 [PMID: 23480440]
  135. Blood. 2007 Sep 1;110(5):1530-9 [PMID: 17495133]
  136. Redox Biol. 2024 Aug;74:103194 [PMID: 38852200]
  137. N Engl J Med. 2018 Oct 11;379(15):1431-1442 [PMID: 30304656]
  138. Science. 2009 May 22;324(5930):1029-33 [PMID: 19460998]
  139. PLoS Biol. 2015 Jul 16;13(7):e1002202 [PMID: 26181372]
  140. J Crit Care. 2014 Jun;29(3):334-9 [PMID: 24559577]
  141. Shock. 2011 Jul;36(1):38-44 [PMID: 21368717]
  142. Cell Rep. 2022 Jun 21;39(12):110986 [PMID: 35732125]
  143. Sci Adv. 2021 Nov 12;7(46):eabi8602 [PMID: 34767443]
  144. Aust Crit Care. 2024 Mar;37(2):369-379 [PMID: 37734999]
  145. Lancet Infect Dis. 2019 Dec;19(12):e422-e436 [PMID: 31630991]
  146. Front Immunol. 2019 Aug 07;10:1878 [PMID: 31440253]
  147. J Clin Invest. 2019 Feb 1;129(2):631-646 [PMID: 30431439]
  148. Am J Obstet Gynecol. 2017 Jan;216(1):60.e1-60.e17 [PMID: 27615440]
  149. Crit Care. 2006;10(6):R166 [PMID: 17129388]
  150. Scand J Trauma Resusc Emerg Med. 2019 Apr 30;27(1):51 [PMID: 31039813]
  151. Oncogene. 2020 Apr;39(16):3292-3304 [PMID: 32071396]
  152. Blood. 2020 Jun 4;135(23):2041-2048 [PMID: 32232482]
  153. Crit Care. 2022 Jan 28;26(1):29 [PMID: 35090526]
  154. Cell Rep. 2024 Feb 27;43(2):113746 [PMID: 38329873]
  155. Science. 1964 Mar 27;143(3613):1457-9 [PMID: 14107454]
  156. Clin Transl Med. 2023 Jan;13(1):e1170 [PMID: 36629024]
  157. Cell. 2024 May 9;187(10):2375-2392.e33 [PMID: 38653238]
  158. J Immunol. 2018 Mar 1;200(5):1781-1789 [PMID: 29386257]
  159. Am J Surg. 1996 Feb;171(2):221-6 [PMID: 8619454]
  160. Cochrane Database Syst Rev. 2017 Jan 31;1:CD008075 [PMID: 28141912]
  161. Lancet. 1999 Aug 7;354(9177):505-8 [PMID: 10465191]
  162. Crit Care Med. 2014 Sep;42(9):2007-18 [PMID: 24942511]
  163. Arthritis Res Ther. 2021 Feb 15;23(1):56 [PMID: 33588937]
  164. Cell Metab. 2015 Feb 3;21(2):347 [PMID: 29510100]
  165. J Immunol. 2017 Feb 1;198(3):1320-1333 [PMID: 28031340]
  166. Innate Immun. 2015 Feb;21(2):115-26 [PMID: 24406749]
  167. Nat Commun. 2024 Jan 2;15(1):163 [PMID: 38167945]
  168. Immun Inflamm Dis. 2023 Oct;11(10):e1042 [PMID: 37904710]
  169. Shock. 2018 Feb;49(2):120-125 [PMID: 28767543]
  170. Immunology. 2018 Feb;153(2):190-202 [PMID: 29064085]
  171. Cancer Sci. 2019 May;110(5):1510-1517 [PMID: 30844107]
  172. Crit Care. 2013 May 11;17(3):R85 [PMID: 23663657]
  173. EBioMedicine. 2021 Nov;73:103627 [PMID: 34656878]
  174. Crit Care Med. 2010 Aug;38(8):1685-94 [PMID: 20562702]
  175. Exp Cell Res. 2020 Mar 15;388(2):111846 [PMID: 31945319]
  176. Nat Rev Immunol. 2020 Feb;20(2):85-86 [PMID: 31819164]
  177. Shock. 2020 Jul;54(1):70-77 [PMID: 31764616]
  178. J Microbiol Immunol Infect. 2019 Jun;52(3):418-425 [PMID: 28923305]
  179. J Clin Invest. 1958 Feb;37(2):255-63 [PMID: 13513756]
  180. Ann Neurol. 1977 May;1(5):409-17 [PMID: 617259]
  181. Mil Med Res. 2022 Oct 9;9(1):56 [PMID: 36209190]
  182. Front Immunol. 2020 Oct 06;11:587913 [PMID: 33123172]
  183. Cytokine. 2023 Jan;161:156057 [PMID: 36208532]
  184. Ann N Y Acad Sci. 1965 Jul 31;119(3):1133-41 [PMID: 5216444]
  185. Pharmaceuticals (Basel). 2022 Jan 26;15(2): [PMID: 35215257]
  186. Chest. 1992 Jun;101(6):1644-55 [PMID: 1303622]
  187. Biochem J. 2005 Dec 15;392(Pt 3):655-64 [PMID: 16104846]
  188. Emerg Med Int. 2022 Jun 24;2022:9222379 [PMID: 35784641]
  189. Rev Bras Hematol Hemoter. 2013;35(3):189-91 [PMID: 23904809]
  190. Circ Res. 2022 May 27;130(11):1662-1681 [PMID: 35440172]
  191. Nat Rev Immunol. 2021 Mar;21(3):151-161 [PMID: 32839570]
  192. Crit Care. 2020 Oct 19;24(1):617 [PMID: 33076951]
  193. Cancer Immunol Immunother. 2018 Sep;67(9):1331-1348 [PMID: 29974196]
  194. Immunity. 2014 Jul 17;41(1):14-20 [PMID: 25035950]
  195. Intensive Care Med. 2021 Nov;47(11):1181-1247 [PMID: 34599691]
  196. Neurosci Biobehav Rev. 2016 Sep;68:1-19 [PMID: 27179453]
  197. Exp Mol Med. 2023 Oct;55(10):2238-2247 [PMID: 37779146]
  198. Front Oncol. 2022 Mar 10;12:842356 [PMID: 35359405]
  199. Shock. 1996 Aug;6(2):89-94 [PMID: 8856841]
  200. J Immunol. 2008 Apr 1;180(7):4697-705 [PMID: 18354193]
  201. Acta Physiol (Oxf). 2018 Jun;223(2):e13042 [PMID: 29377587]
  202. IUBMB Life. 2012 Jan;64(1):1-9 [PMID: 22131303]
  203. N Engl J Med. 2014 May 1;370(18):1750-1 [PMID: 24635774]
  204. Cell Mol Biol Lett. 2024 May 30;29(1):81 [PMID: 38816685]
  205. Nucleic Acids Res. 2012 Jun;40(11):4794-803 [PMID: 22323521]
  206. Trends Genet. 2022 Feb;38(2):124-127 [PMID: 34627643]
  207. Crit Care. 2013 May 30;17(3):R105 [PMID: 23721745]
  208. Mediators Inflamm. 2017;2017:9029327 [PMID: 29386753]
  209. Mayo Clin Proc. 2013 Oct;88(10):1127-40 [PMID: 24079682]
  210. Intensive Care Med. 2007 Mar;33(3):406-8 [PMID: 17242932]
  211. Cytokine Growth Factor Rev. 2022 Dec;68:81-92 [PMID: 36376165]
  212. Biochim Biophys Acta Mol Basis Dis. 2019 Dec 1;1865(12):165542 [PMID: 31473341]
  213. PLoS Pathog. 2018 Oct 31;14(10):e1007405 [PMID: 30379932]
  214. J Leukoc Biol. 2020 Jul;108(1):427-437 [PMID: 32480431]
  215. Cell Rep. 2018 Aug 14;24(7):1902-1915.e6 [PMID: 30110645]
  216. Clin Microbiol Infect. 2000 Dec;6(12):657-60 [PMID: 11284925]
  217. Crit Care Med. 2004 Mar;32(3):858-73 [PMID: 15090974]
  218. Crit Care Med. 2020 Dec;48(12):e1194-e1202 [PMID: 33003077]
  219. Diabetes. 1983 Feb;32(2):181-91 [PMID: 6337898]
  220. Front Immunol. 2022 Nov 25;13:1061544 [PMID: 36505495]
  221. Sci China Life Sci. 2021 Nov;64(11):1895-1905 [PMID: 33580429]
  222. Cell Rep. 2020 Dec 15;33(11):108500 [PMID: 33326785]
  223. J Cell Biol. 2010 Sep 6;190(5):881-92 [PMID: 20819940]
  224. J Infect Dis. 2012 Feb 1;205(3):392-400 [PMID: 22180620]
  225. J Clin Med. 2019 Jan 10;8(1): [PMID: 30634576]
  226. Immunity. 2013 Jul 25;39(1):1-10 [PMID: 23890059]
  227. Expert Opin Ther Targets. 2023 Jul-Dec;27(7):575-591 [PMID: 37477229]
  228. Front Cell Infect Microbiol. 2021 Feb 26;11:624607 [PMID: 33718271]
  229. J Neurosci. 2019 Jun 5;39(23):4422-4433 [PMID: 30926749]
  230. J Biol Chem. 2015 Jan 2;290(1):46-55 [PMID: 25406319]
  231. J Clin Invest. 1958 Feb;37(2):244-54 [PMID: 13513755]
  232. Cell Metab. 2022 Aug 2;34(8):1137-1150.e6 [PMID: 35820416]
  233. Mol Ther. 2020 Nov 4;28(11):2442-2457 [PMID: 32966775]
  234. Am J Respir Crit Care Med. 2003 Jun 15;167(12):1641-9 [PMID: 12626348]
  235. Cancer Cell. 2022 Feb 14;40(2):201-218.e9 [PMID: 35090594]
  236. Front Immunol. 2022 Oct 18;13:1013686 [PMID: 36330516]
  237. J Leukoc Biol. 2003 Apr;73(4):482-92 [PMID: 12660223]
  238. APMIS. 2022 Aug;130(8):507-514 [PMID: 35349738]
  239. Int J Oncol. 2011 Aug;39(2):453-63 [PMID: 21617859]
  240. EBioMedicine. 2018 Apr;30:303-316 [PMID: 29463472]
  241. Physiology (Bethesda). 2017 Nov;32(6):453-463 [PMID: 29021365]
  242. J Immunol. 2016 Nov 1;197(9):3607-3617 [PMID: 27683749]
  243. Clin Exp Immunol. 2007 Mar;147(3):426-39 [PMID: 17302891]
  244. Crit Care Med. 2004 Aug;32(8):1637-42 [PMID: 15286537]
  245. Cancers (Basel). 2020 Jul 28;12(8): [PMID: 32731406]
  246. Crit Care Med. 2014 Sep;42(9):2118-25 [PMID: 24797375]
  247. EMBO Rep. 2022 Dec 6;23(12):e54685 [PMID: 36215678]
  248. Immunohorizons. 2024 Jan 1;8(1):74-88 [PMID: 38226924]
  249. Sci Adv. 2022 Apr 29;8(17):eabm8965 [PMID: 35476437]
  250. Cell Metab. 2006 Mar;3(3):177-85 [PMID: 16517405]
  251. J Appl Physiol (1985). 2016 Jan 15;120(2):226-35 [PMID: 26066826]
  252. J Surg Res. 1998 Nov;80(1):44-51 [PMID: 9790813]
  253. Nature. 2019 Oct;574(7779):575-580 [PMID: 31645732]
  254. Front Immunol. 2022 Apr 29;13:833479 [PMID: 35572571]
  255. Ann Am Thorac Soc. 2015 Nov;12(11):1662-6 [PMID: 26356483]
  256. Cell Mol Bioeng. 2020 Sep 21;13(5):541-557 [PMID: 33184582]
  257. Biomed Res Int. 2015;2015:903720 [PMID: 25821827]
  258. Clin Sci (Lond). 2024 Jan 10;138(1):65-85 [PMID: 38197178]
  259. Physiol Rev. 2019 Apr 1;99(2):1223-1248 [PMID: 30758246]
  260. Nature. 2021 Nov;599(7885):471-476 [PMID: 34732892]
  261. Cell Death Differ. 2022 Jan;29(1):133-146 [PMID: 34363018]
  262. Cell Rep. 2018 Feb 6;22(6):1509-1521 [PMID: 29425506]
  263. Vet Immunol Immunopathol. 2020 Aug;226:110074 [PMID: 32540687]
  264. Cancer Med. 2018 Sep;7(9):4690-4700 [PMID: 30051648]
  265. Front Immunol. 2020 Jul 03;11:1299 [PMID: 32719675]
  266. Intensive Care Med. 1996 Jan;22(1):17-25 [PMID: 8857433]
  267. Indian J Clin Biochem. 2016 Apr;31(2):240-2 [PMID: 27069334]
  268. J Immunol. 2013 Sep 15;191(6):3090-9 [PMID: 23956421]
  269. Nat Rev Cardiol. 2023 Mar;20(3):197-210 [PMID: 36198871]
  270. J Clin Oncol. 1996 Aug;14(8):2217-23 [PMID: 8708710]
  271. Crit Care Med. 2015 Mar;43(3):567-73 [PMID: 25479113]
  272. Front Immunol. 2022 Jan 06;12:786666 [PMID: 35069560]
  273. J Cardiovasc Surg (Torino). 1962 Aug;3:323-6 [PMID: 13966175]
  274. Crit Care Med. 2012 Dec;40(12):3162-9 [PMID: 22971588]
  275. PLoS One. 2016 Nov 15;11(11):e0163694 [PMID: 27846210]
  276. Front Immunol. 2023 Apr 03;14:1110070 [PMID: 37077915]
  277. Crit Care. 2014 Jun 24;18(3):R130 [PMID: 24962182]
  278. Front Immunol. 2018 Nov 12;9:2564 [PMID: 30483253]
  279. Invest New Drugs. 2020 Jun;38(3):855-865 [PMID: 31388792]
  280. J Immunol. 2013 Aug 1;191(3):1486-95 [PMID: 23817426]
  281. Eur J Pharmacol. 2022 Jun 5;924:174959 [PMID: 35430208]
  282. Yeungnam Univ J Med. 2021 Jul;38(3):183-193 [PMID: 33596629]
  283. FEMS Immunol Med Microbiol. 2011 Mar;61(2):153-8 [PMID: 21118312]
  284. Mol Cell Biochem. 1999 Aug;198(1-2):113-8 [PMID: 10497885]
  285. Front Immunol. 2023 Jan 26;14:1101918 [PMID: 36776839]
  286. Eur J Anaesthesiol Suppl. 2008;42:146-53 [PMID: 18289433]
  287. Nat Metab. 2024 Apr;6(4):708-723 [PMID: 38499763]
  288. Shock. 2022 Mar 1;57(3):378-383 [PMID: 34628453]
  289. Front Cell Dev Biol. 2019 Jan 29;7:4 [PMID: 30761299]
  290. Crit Care Med. 1987 May;15(5):489-90 [PMID: 3568712]
  291. Cell Metab. 2019 Dec 3;30(6):1055-1074.e8 [PMID: 31708446]
  292. N Engl J Med. 1996 Mar 21;334(12):799; author reply 800 [PMID: 8592561]
  293. JAMA. 2019 Oct 1;322(13):1244-1245 [PMID: 31573619]
  294. Nature. 2019 Jan;565(7740):495-499 [PMID: 30626970]
  295. Front Immunol. 2017 Aug 15;8:975 [PMID: 28861083]
  296. Front Immunol. 2021 Aug 16;12:696536 [PMID: 34484194]
  297. Mol Med. 2018 May 29;24(1):26 [PMID: 30134811]
  298. Science. 2024 Apr 5;384(6691):eabo7027 [PMID: 38574142]
  299. Cancer Cell. 2006 Jun;9(6):425-34 [PMID: 16766262]
  300. Nat Immunol. 2023 Aug;24(8):1358-1369 [PMID: 37365386]

MeSH Term

Humans
Sepsis
Lactic Acid
Animals
Monocarboxylic Acid Transporters
Biomarkers
Receptors, G-Protein-Coupled
Hypoxia-Inducible Factor 1, alpha Subunit
Protein Processing, Post-Translational
Muscle Proteins
Symporters

Chemicals

Lactic Acid
Monocarboxylic Acid Transporters
Biomarkers
Receptors, G-Protein-Coupled
Hypoxia-Inducible Factor 1, alpha Subunit
monocarboxylate transport protein 1
HCAR1 protein, human
Muscle Proteins
Symporters
SLC16A4 protein, human

Word Cloud

Created with Highcharts 10.0.0immunelactatecellsepsisrolecellsfunctionlactylationLactatesignificantlyimpactssepticshocktranscendingtraditionalviewjustmetabolicbyproductreviewsummarizesbiomarkerinfluencedynamicsemphasizingcriticalmodulatingresponsesMechanisticallykeytransporterslikeMCT1MCT4receptorGPR81crucialmediatingeffectsHIF-1αalsoplayssignificantlactate-drivenmodulationAdditionallyaffectspost-translationalmodificationsacetylationphosphorylationalterenzymeactivitiesproteinfunctionsinteractionscentralunderstandingsepsis-associateddysregulationofferinginsightscanguidefutureresearchimprovetherapeuticstrategiesenhancepatientoutcomesLactate'simpactsepsis:unravelingcomplexinterplayresponseimmunosuppressioninflammationlacticacid

Similar Articles

Cited By